Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001731122-24-001154
Filing Date
2024-07-29
Accepted
2024-07-29 17:21:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 e5831_s-3.htm S-3 221803
2 EXHIBIT 5.1 e5831_ex5-1.htm EX-5.1 9930
3 EXHIBIT 23.1 e5831_ex23-1.htm EX-23.1 2452
4 EXHIBIT 107 e5831_ex107.htm EX-FILING FEES 18385
5 GRAPHIC image_001.gif GRAPHIC 2822
6 GRAPHIC image_007.jpg GRAPHIC 25346
  Complete submission text file 0001731122-24-001154.txt   292757
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-281089 | Film No.: 241153491
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)